WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent of -$300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTaxParent · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax, parent for the quarter ending 2026-06-30 was -$300.00K, a 137.50% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax, parent for the quarter ending 2026-03-31 was $100.00K, a 88.89% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax, parent for the quarter ending 2025-09-30 was -$500.00K, a 145.45% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments, tax, parent for the quarter ending 2025-06-30 was $800.00K, a 166.67% increase year-over-year.
| Period end | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent 3 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent 6 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax, Parent 9 month |
|---|---|---|---|
| 2026-06-30 | -$300.00K 10-Q · filed 2026-07-23 | -$200.00K 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $100.00K 10-Q · filed 2026-04-23 | ||
| 2025-09-30 | -$500.00K 10-Q · filed 2025-10-23 | $300.00K derived: sum of 2 quarters · filed 2026-07-23 | $1.20M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $800.00K 10-Q · filed 2026-07-23 | $1.70M 10-Q · filed 2026-07-23 | |
| 2025-03-31 | $900.00K 10-Q · filed 2026-04-23 | ||
| 2024-09-30 | $1.10M 10-Q · filed 2025-10-23 | $1.40M derived: sum of 2 quarters · filed 2025-10-23 | $700.00K 10-Q · filed 2025-10-23 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-07-24 | -$400.00K 10-Q · filed 2025-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |